Home / Business and Economy / Teladoc's Q2 Revenue Beats Estimates, but Sales Decline Persists
Teladoc's Q2 Revenue Beats Estimates, but Sales Decline Persists
29 Jul
Summary
- Teladoc's Q2 2025 revenue exceeded market expectations
- Sales fell 1.6% year-on-year to $631.9 million
- Company expects 2.4% year-on-year decline in Q3 2025
In the second quarter of 2025, digital medical services platform Teladoc Health (NYSE:TDOC) reported results that exceeded the market's revenue expectations. However, the company's sales fell by 1.6% year-on-year to $631.9 million.
Looking ahead, Teladoc expects its revenue for the next quarter to be around $625 million, close to analysts' estimates. The company's GAAP loss of $0.19 per share was 27.8% above analysts' consensus estimates.
Despite the mixed results, Teladoc's CEO, Chuck Divita, expressed satisfaction with the company's performance. "I'm pleased with our performance in the second quarter, with consolidated revenue and adjusted EBITDA both at the higher end of our guidance ranges," he said. Divita noted that the results reflect "continued disciplined execution" and build on the solid performance from the first quarter.
Founded to help people in rural areas access online medical consultations, Teladoc Health has struggled with sluggish revenue growth over the past three years, with an annualized rate of just 4.4%. This falls short of the benchmark for the consumer internet sector, presenting a challenge as the company works to advance its strategic priorities and invest in products and capabilities.
